4040 Civic Center Drive
Suite 200
San Rafael, CA 94903
United States
https://claritaspharma.com
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Robert Farrell J.D. | Chairman, CEO & President | 300k | N/D | N/D |
Ms. Victoria Diana Rudman | Interim CFO, Treasurer & Secretary | 75k | N/D | 1968 |
Mr. Seth Yakatan | Co-Founder | 22,5k | N/D | 1970 |
Dr. Stuart L. Silverman | Co-Chair of Scientific Advisory Board and Vice President of Medical Affairs | N/D | N/D | 1947 |
Dr. Sari Prutchi-Sagiv Ph.D. | Chief Scientific Officer | 146k | N/D | N/D |
Dr. Moshe Yeshurun M.D. | Chief Medical Officer | 86k | N/D | N/D |
Dr. Amos Rosenthal Ph.D. | Head of Chemistry | N/D | N/D | N/D |
Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.
L'ISS Governance QualityScore di Claritas Pharmaceuticals, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.